1. Home
  2. TMDX vs FIZZ Comparison

TMDX vs FIZZ Comparison

Compare TMDX & FIZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • FIZZ
  • Stock Information
  • Founded
  • TMDX 1998
  • FIZZ 1985
  • Country
  • TMDX United States
  • FIZZ United States
  • Employees
  • TMDX N/A
  • FIZZ N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • FIZZ Beverages (Production/Distribution)
  • Sector
  • TMDX Health Care
  • FIZZ Consumer Staples
  • Exchange
  • TMDX Nasdaq
  • FIZZ Nasdaq
  • Market Cap
  • TMDX 4.0B
  • FIZZ 3.4B
  • IPO Year
  • TMDX 2019
  • FIZZ 1991
  • Fundamental
  • Price
  • TMDX $130.67
  • FIZZ $35.84
  • Analyst Decision
  • TMDX Buy
  • FIZZ Strong Sell
  • Analyst Count
  • TMDX 12
  • FIZZ 1
  • Target Price
  • TMDX $128.92
  • FIZZ $39.00
  • AVG Volume (30 Days)
  • TMDX 868.2K
  • FIZZ 233.3K
  • Earning Date
  • TMDX 10-29-2025
  • FIZZ 12-04-2025
  • Dividend Yield
  • TMDX N/A
  • FIZZ N/A
  • EPS Growth
  • TMDX 2163.11
  • FIZZ 0.66
  • EPS
  • TMDX 2.02
  • FIZZ 1.98
  • Revenue
  • TMDX $531,292,000.00
  • FIZZ $1,202,396,000.00
  • Revenue This Year
  • TMDX $38.78
  • FIZZ $2.80
  • Revenue Next Year
  • TMDX $20.76
  • FIZZ $2.19
  • P/E Ratio
  • TMDX $64.68
  • FIZZ $18.11
  • Revenue Growth
  • TMDX 48.09
  • FIZZ 0.46
  • 52 Week Low
  • TMDX $55.00
  • FIZZ $35.49
  • 52 Week High
  • TMDX $145.50
  • FIZZ $50.51
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 69.28
  • FIZZ 31.11
  • Support Level
  • TMDX $108.34
  • FIZZ $35.66
  • Resistance Level
  • TMDX $118.51
  • FIZZ $36.71
  • Average True Range (ATR)
  • TMDX 6.15
  • FIZZ 0.71
  • MACD
  • TMDX 1.78
  • FIZZ 0.15
  • Stochastic Oscillator
  • TMDX 86.45
  • FIZZ 15.75

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About FIZZ National Beverage Corp.

National Beverage Corp is a non-alcoholic beverage company in the U.S. Its portfolio skews toward functional drinks (that is those purporting to offer health benefits) and is anchored by the popular LaCroix sparkling water trademark. Other offerings include Rip It energy drinks, Everfresh juices, and soda brands like Shasta and Faygo. The firm controls the majority of its production and distribution apparatus, with very little outsourcing. In terms of go-to-market, it uses warehouse distribution for retailers, direct-store delivery for convenience stores and other small outlets, and food-service distributors for the food-service channel (schools, hospitals, restaurants).

Share on Social Networks: